DOT Drug Panel Changes – How Will It Affect Canadian Non-DOT Testing?

Changes are Coming As part of the U.S. Department of Transportation (DOT) January 23, 2017’s Notice of Proposed Rulemaking (NPR), the standard Substance Abuse and Mental Health Services Administration (SAMHSA) panel for drug testing may be changing this October 1, 2017 if the rule is finalized. Current SAMHSA panel: Initial Analyte Screening Cut-off Confirmatory Analyte Confirmation … Continued

New on the Scene: Carfentanil

Opioid Crisis Continues Rampant opioid abuse remains a huge public health crisis in Canada, where fentanyl overdoses have become a relatively common scene for police and health care professionals. Now a new substance has been found on Canadian streets called carfentanil which is adding more fuel to an already uncontrollable fire of addictions and overdoses. … Continued

Prescription Drug Testing in the Workplace

Does it belong? Workplace safety is of the utmost importance for employers and employees, which is why it is so important to have policies regarding drug and alcohol use in the workplace. But what exactly should be covered within these policies? There have been questions arising with regard to the substances that are often not … Continued